Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,933 shares at $319.03 ($948K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $948k ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $319.03 | 135 | $43K | 4.5% |
| 2 | $320.01 | 129 | $41K | 4.4% |
| 3 | $320.81 | 274 | $88K | 9.3% |
| 4 | $321.82 | 368 | $118K | 12.5% |
| 5 | $323.01 | 444 | $143K | 15.1% |
| 6 | $323.84 | 973 |
| $315K |
| 33.3% |
| 7 | $324.88 | 345 | $112K | 11.8% |
| 8 | $325.67 | 265 | $86K | 9.1% |
| Total | $323.08 avg | 2,933 | $948K | 100% |
| Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $8.1M | — | Filing → |